No Data
No Data
MegaMedical-B (06622.HK) will hold a board of directors meeting on August 29 to approve the interim performance.
On August 16, Glorious Sun Ophthalmic (6622.HK) announced that the board of directors will hold a meeting on August 29, 2024 to approve the midterm performance of the company and its subsidiaries for the six months ending June 30, 2024 and to publish its announcement.
ZHAOKE OPHTH-B: NOTICE OF BOARD MEETING
Zhaoke Ophthalmology Expects Losses to Shrink in H1
Express News | Corrected-Zhaoke Ophthalmology H1 Net Income RMB -77 Million (Corrects Amount)
Megvii Ophthalmology-B (06622) issued a profit warning, expecting the mid-term loss to narrow by no more than 77 million yuan year on year.
Megain Medical Group-B (06622) has released an announcement stating that the board of directors expects the group to negotiate with the creditors and reach a debt restructuring agreement by June 30, 2024...
Express News | Zhaoke Ophthalmology - Expected Result Due to Decrease in Research and Development Expenses Associated With Nvk002 and Tab014, Among Others
No Data